AllianceBernstein’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-49,700
| Closed | -$133K | – | 3281 |
|
|
2022
Q1 | $133K | Buy |
49,700
+200
| +0.4% | +$535 | ﹤0.01% | 3067 |
|
|
2021
Q4 | $214K | Sell |
49,500
-900
| -2% | -$3.89K | ﹤0.01% | 3039 |
|
|
2021
Q3 | $257K | Sell |
50,400
-6,700
| -12% | -$34.2K | ﹤0.01% | 2996 |
|
|
2021
Q2 | $361K | Buy |
57,100
+10,300
| +22% | +$65.1K | ﹤0.01% | 2944 |
|
|
2021
Q1 | $362K | Sell |
46,800
-16,100
| -26% | -$125K | ﹤0.01% | 2811 |
|
|
2020
Q4 | $412K | Hold |
62,900
| – | – | ﹤0.01% | 2667 |
|
|
2020
Q3 | $418K | Sell |
62,900
-1,500
| -2% | -$9.97K | ﹤0.01% | 2612 |
|
|
2020
Q2 | $536K | Hold |
64,400
| – | – | ﹤0.01% | 2558 |
|
|
2020
Q1 | $494K | Buy |
64,400
+5,600
| +10% | +$43K | ﹤0.01% | 2352 |
|
|
2019
Q4 | $489K | Sell |
58,800
-87,837
| -60% | -$730K | ﹤0.01% | 2548 |
|
|
2019
Q3 | $1.08M | Sell |
146,637
-21,350
| -13% | -$158K | ﹤0.01% | 2205 |
|
|
2019
Q2 | $1.89M | Hold |
167,987
| – | – | ﹤0.01% | 2003 |
|
|
2019
Q1 | $1.81M | Buy |
167,987
+69,917
| +71% | +$752K | ﹤0.01% | 1947 |
|
|
2018
Q4 | $1.48M | Hold |
98,070
| – | – | ﹤0.01% | 1995 |
|
|
2018
Q3 | $1.81M | Hold |
98,070
| – | – | ﹤0.01% | 2004 |
|
|
2018
Q2 | $2.24M | Buy |
98,070
+23,800
| +32% | +$544K | ﹤0.01% | 1820 |
|
|
2018
Q1 | $2.11M | Sell |
74,270
-7,720
| -9% | -$220K | ﹤0.01% | 1772 |
|
|
2017
Q4 | $1.73M | Buy |
81,990
+8,300
| +11% | +$175K | ﹤0.01% | 1941 |
|
|
2017
Q3 | $1.34M | Hold |
73,690
| – | – | ﹤0.01% | 2105 |
|
|
2017
Q2 | $1.14M | Buy |
73,690
+39,090
| +113% | +$606K | ﹤0.01% | 2208 |
|
|
2017
Q1 | $598K | Buy |
+34,600
| New | +$598K | ﹤0.01% | 2460 |
|